Wockhardt Limited
₹1,363.2+1.44%Apr 13, 3:45 PM IST
WOCKPHARMA•Health Technology•Pharmaceuticals: Major
Current Price
₹1,363.2+1.44%
Apr 13, 3:45 PM ISTMarket Cap₹21,838.87 Cr
Market Cap₹21,838.87 Cr
Business Overview
Wockhardt Limited operates through 4 main business divisions including Pharmaceuticals, Biotechnology, Healthcare (Wockhardt Hospitals), Vaccines.
Business Hierarchy Structure for Wockhardt Limited
- Wockhardt Limited
- Pharmaceuticals
- New Drug Discovery Programme
- Antibiotics
- EMROK (WCK 771)
- EMROK O (WCK 2349)
- ZAYNICH (WCK 5222)
- MIQNAF (WCK 4873)
- WCK 4282
- WCK 6777
- Diabetes & Biologicals
- Recombinant Human Insulin (WOSULIN)
- Recombinant Insulin Glargine (GLARITUS)
- GLP-1 agonists
- Other Therapeutic Areas
- Immunology
- Endocrinology
- Oncology
- Antibiotics
- New Drug Discovery Programme
- Biotechnology
- Biosimilars
- Biobetters
- Recombinant Hepatitis-B Vaccine (Biovac-B)
- Recombinant Human Erythropoietin (WEPOX)
- Healthcare (Wockhardt Hospitals)
- Super-specialty Hospitals
- Mumbai Hospitals
- Nagpur Hospitals
- Rajkot Hospital
- Services Offered
- Internal Medicine
- Paediatrics
- Paediatric Surgery
- General and Bariatric Surgery
- Gastroenterology
- Oncology
- Orthopaedics
- Trauma Surgery
- Endocrinology
- Intensive Care
- Nephrology
- Neurology
- Obstetrics
- Gynaecology
- Cardiology
- Cardiothoracic Surgery
- Kidney transplants
- Liver transplants
- Bone marrow transplants
- Regenerative Medicine
- Stem Cells Therapies
- Growth Factor Concentrate (GFC) therapies
- Hair Therapy
- Skin Therapy
- Joints Therapy
- Wound Healing Therapy
- Other Products
- Wocktox (thin-film and high stability botox)
- Super-specialty Hospitals
- Vaccines
- Future foray into Vaccines (other than COVID)
- Pharmaceuticals